{"transactions":[{"id":740040,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-06-12T20:17:30.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 10, 2026 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 10, 2026, subject to the Reporting Person providing continuous service through such date."}],"balance_after":9250,"derivative":{"exercise_price":13.22,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001213029-26-000007","document":"form4-06122026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000121302926000007/form4-06122026_080623.xml","form_type":"4"}},{"id":743864,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2026-06-10T20:05:26.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":6111,"derivative":{"exercise_price":100.64,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001213029-26-000005","document":"wk-form4_1781121922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000121302926000005/wk-form4_1781121922.xml","form_type":"4"}},{"id":743863,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:05:26.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12894,"source":{"system":"sec-edgar","filing":"0001213029-26-000005","document":"wk-form4_1781121922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000121302926000005/wk-form4_1781121922.xml","form_type":"4"}},{"id":831418,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-23T20:36:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":888,"price":111.75,"value":99234.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":13873.623,"source":{"system":"sec-edgar","filing":"0001090872-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000037/form4.xml","form_type":"4"}},{"id":831417,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-23T20:36:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":2158,"price":111.75,"value":241156.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"85.693 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":12985.623,"source":{"system":"sec-edgar","filing":"0001090872-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000037/form4.xml","form_type":"4"}},{"id":866720,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:22.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007640","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007640/form4.xml","form_type":"4"}},{"id":1114198,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2025-06-12T20:31:17.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9216,"derivative":{"exercise_price":70.07,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":9216},"source":{"system":"sec-edgar","filing":"0001628280-25-031014","document":"wk-form4_1749760266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031014/wk-form4_1749760266.xml","form_type":"4"}},{"id":1114197,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:31:17.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11252,"source":{"system":"sec-edgar","filing":"0001628280-25-031014","document":"wk-form4_1749760266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031014/wk-form4_1749760266.xml","form_type":"4"}},{"id":1114855,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T22:00:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125022227/form4.xml","form_type":"4"}},{"id":1142914,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-05-19T22:45:21.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following May 15, 2025 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of May 15, 2025, subject to the Reporting Person providing continuous service through such date."}],"balance_after":130000,"derivative":{"exercise_price":0.4017,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-25-013710","document":"form4-05192025_100517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141588925013710/form4-05192025_100517.xml","form_type":"4"}},{"id":1183711,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T19:46:01.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":35640,"price":0.56,"value":19958.4,"ownership":{"direct":true},"balance_after":35640,"source":{"system":"sec-edgar","filing":"0001415889-25-009604","document":"form4-04022025_070458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141588925009604/form4-04022025_070458.xml","form_type":"4"}},{"id":1201695,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-18T13:56:18.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":812,"price":121.18,"value":98398.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":10741.93,"source":{"system":"sec-edgar","filing":"0001127602-25-009720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760225009720/form4.xml","form_type":"4"}},{"id":1201694,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-18T13:56:18.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":1819,"price":121.18,"value":220426.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"55.473 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":9929.93,"source":{"system":"sec-edgar","filing":"0001127602-25-009720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760225009720/form4.xml","form_type":"4"}},{"id":1469463,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T20:05:07.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124031290/form4.xml","form_type":"4"}},{"id":1477390,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-06-17T20:07:23.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 14, 2024 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 14, 2024, subject to the Reporting Person providing continuous service through such date."}],"balance_after":130000,"derivative":{"exercise_price":2.36,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-24-017147","document":"form4-06172024_080619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000141588924017147/form4-06172024_080619.xml","form_type":"4"}},{"id":1479850,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2024-06-14T16:15:43.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12517,"derivative":{"exercise_price":59.94,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0000879169-24-000094","document":"wk-form4_1718381735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000094/wk-form4_1718381735.xml","form_type":"4"}},{"id":1479849,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:15:43.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":2830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8734,"source":{"system":"sec-edgar","filing":"0000879169-24-000094","document":"wk-form4_1718381735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000094/wk-form4_1718381735.xml","form_type":"4"}},{"id":1570451,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-19T22:19:39.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":750,"price":147.48,"value":110610.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8055.457,"source":{"system":"sec-edgar","filing":"0001127602-24-010681","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224010681/form4.xml","form_type":"4"}},{"id":1570450,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-19T22:19:39.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1678,"price":147.48,"value":247471.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"42.181 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":7305.457,"source":{"system":"sec-edgar","filing":"0001127602-24-010681","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224010681/form4.xml","form_type":"4"}},{"id":1784762,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-09-08T20:22:13.000Z","date":"2023-09-08","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On September 6, 2023, to align with benchmarking data, the issuer's Compensation Committee amended the Non-Employee Director Compensation Policy to increase the annual equity grant to non-employee directors. The Reporting Person was granted an option to purchase 65,000 shares on June 16, 2023, prior to the amendment of the policy. This additional option grant aligns the Reporting Person's total 2023 grants with the updated policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person providing continuous service through such date."}],"balance_after":55000,"derivative":{"exercise_price":3.19,"expiration_date":"2033-09-07","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-23-048782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919123048782/doc4.xml","form_type":"4"}},{"id":1828606,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T21:29:17.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034838/form4.xml","form_type":"4"}},{"id":1849693,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-20T20:41:53.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected\nor the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person\nproviding continuous service through such date."}],"balance_after":65000,"derivative":{"exercise_price":3.19,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-23-038435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919123038435/doc4.xml","form_type":"4"}},{"id":1853310,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-16T20:00:34.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":11294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":11294,"derivative":{"exercise_price":61.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":11294},"source":{"system":"sec-edgar","filing":"0001209191-23-037793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037793/doc4.xml","form_type":"4"}},{"id":1853309,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:34.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":5904,"source":{"system":"sec-edgar","filing":"0001209191-23-037793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037793/doc4.xml","form_type":"4"}},{"id":1945049,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T01:34:35.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":741,"price":136.82,"value":101383.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":5585.276,"source":{"system":"sec-edgar","filing":"0000899243-23-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000089924323009212/doc4.xml","form_type":"4"}},{"id":1945048,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T01:34:35.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":1658,"price":136.82,"value":226847.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"20.375 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":4844.276,"source":{"system":"sec-edgar","filing":"0000899243-23-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000089924323009212/doc4.xml","form_type":"4"}},{"id":2219409,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:15:48.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122024468/form4.xml","form_type":"4"}},{"id":2228896,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:00:22.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9124,"derivative":{"exercise_price":68.55,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":9124},"source":{"system":"sec-edgar","filing":"0001209191-22-037793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037793/doc4.xml","form_type":"4"}},{"id":2228895,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:00:22.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":3399,"source":{"system":"sec-edgar","filing":"0001209191-22-037793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037793/doc4.xml","form_type":"4"}},{"id":2236199,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-10T20:13:19.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected\nor the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person\nproviding continuous service through such date."}],"balance_after":65000,"derivative":{"exercise_price":5.31,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-035853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000120919122035853/doc4.xml","form_type":"4"}},{"id":2323501,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-21T21:05:06.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":797,"price":136.82,"value":109045.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":3165.901,"source":{"system":"sec-edgar","filing":"0001127602-22-010046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760222010046/form4.xml","form_type":"4"}},{"id":2323500,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-21T21:05:06.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":1785,"price":136.82,"value":244223.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"0.901 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":2368.901,"source":{"system":"sec-edgar","filing":"0001127602-22-010046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760222010046/form4.xml","form_type":"4"}},{"id":2503469,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-19T19:10:26.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":179,"price":162.16,"value":29026.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":583,"source":{"system":"sec-edgar","filing":"0001127602-21-029665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760221029665/form4.xml","form_type":"4"}},{"id":2503468,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-19T19:10:26.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":404,"price":162.16,"value":65512.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock."}],"balance_after":404,"source":{"system":"sec-edgar","filing":"0001127602-21-029665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760221029665/form4.xml","form_type":"4"}},{"id":2557109,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-29T22:19:29.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":5910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":5910,"derivative":{"exercise_price":69.26,"expiration_date":"2031-09-26","underlying":"Common Stock","underlying_shares":5910},"source":{"system":"sec-edgar","filing":"0001209191-21-058108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058108/doc4.xml","form_type":"4"}},{"id":2557108,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T22:19:29.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":1255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":1255,"source":{"system":"sec-edgar","filing":"0001209191-21-058108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058108/doc4.xml","form_type":"4"}},{"id":2663664,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:20:51.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021501","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021501/form4.xml","form_type":"4"}},{"id":2989678,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T23:19:08.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on November 3, 2023."}],"balance_after":9000,"derivative":{"exercise_price":2.09,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-024925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120024925/form4.xml","form_type":"4"}}]}